Human respiratory syncytial virus diversity and epidemiology among patients hospitalized with severe respiratory illness in South Africa, 2012-2015
- PMID: 34528769
- PMCID: PMC8818822
- DOI: 10.1111/irv.12905
Human respiratory syncytial virus diversity and epidemiology among patients hospitalized with severe respiratory illness in South Africa, 2012-2015
Abstract
Background: We aimed to describe the prevalence of human respiratory syncytial virus (HRSV) and evaluate associations between HRSV subgroups and/or genotypes and epidemiologic characteristics and clinical outcomes in patients hospitalized with severe respiratory illness (SRI).
Methods: Between January 2012 and December 2015, we enrolled patients of all ages admitted to two South African hospitals with SRI in prospective hospital-based syndromic surveillance. We collected respiratory specimens and clinical and epidemiological data. Unconditional random effect multivariable logistic regression was used to assess factors associated with HRSV infection.
Results: HRSV was detected in 11.2% (772/6908) of enrolled patients of which 47.0% (363/772) were under the age of 6 months. There were no differences in clinical outcomes of HRSV subgroup A-infected patients compared with HRSV subgroup B-infected patients but among patients aged <5 years, children with HRSV subgroup A were more likely be coinfected with Streptococcus pneumoniae (23/208, 11.0% vs. 2/90, 2.0%; adjusted odds ratio 5.7). No significant associations of HRSV A genotypes NA1 and ON1 with specific clinical outcomes were observed.
Conclusions: While HRSV subgroup and genotype dominance shifted between seasons, we showed similar genotype diversity as noted worldwide. We found no association between clinical outcomes and HRSV subgroups or genotypes.
Keywords: South Africa; human respiratory syncytial virus; severe respiratory illness.
© 2021 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
Conflict of interest statement
Cheryl Cohen has received funding to her institution from Sanofi Pasteur, US Centers for Disease Control and Prevention, World Health Organization, and has received funding to attend a meeting from Parexel. Dr. Dawood reports personal fees from Pfizer‐South Africa and conference attendance sponsorship from MSD‐South Africa, Pfizer‐South Africa, and Biomiereux‐South Africa.
Figures
Similar articles
-
[Epidemiology and molecular biology of respiratory syncytial virus among hospitalized children in Guangzhou from 2013 to 2017].Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Mar 6;54(3):294-300. doi: 10.3760/cma.j.issn.0253-9624.2020.03.010. Zhonghua Yu Fang Yi Xue Za Zhi. 2020. PMID: 32187935 Chinese.
-
Differences in viral load among human respiratory syncytial virus genotypes in hospitalized children with severe acute respiratory infections in the Philippines.Virol J. 2016 Jun 27;13:113. doi: 10.1186/s12985-016-0565-8. Virol J. 2016. PMID: 27350282 Free PMC article.
-
A molecular epidemiological study of human respiratory syncytial virus in Croatia, 2011-2014.Infect Genet Evol. 2016 Oct;44:76-84. doi: 10.1016/j.meegid.2016.06.036. Epub 2016 Jun 23. Infect Genet Evol. 2016. PMID: 27340014
-
Emergence of ON1 genotype of human respiratory syncytial virus subgroup A in China between 2011 and 2015.Sci Rep. 2017 Jul 14;7(1):5501. doi: 10.1038/s41598-017-04824-0. Sci Rep. 2017. PMID: 28710393 Free PMC article.
-
Respiratory syncytial virus infections in human beings and in cattle.J Infect. 1994 Sep;29(2):215-28. doi: 10.1016/s0163-4453(94)90866-4. J Infect. 1994. PMID: 7806887 Review.
Cited by
-
Evolutionary dynamics of respiratory syncytial virus in Buenos Aires: Viral diversity, migration, and subgroup replacement.Virus Evol. 2023 Jan 25;9(1):vead006. doi: 10.1093/ve/vead006. eCollection 2023. Virus Evol. 2023. PMID: 36880065 Free PMC article.
-
Molecular epidemiology of respiratory syncytial virus in children with acute respiratory illnesses in Africa: A systematic review and meta-analysis.J Glob Health. 2023 Jan 14;13:04001. doi: 10.7189/jogh.13.04001. J Glob Health. 2023. PMID: 36637855 Free PMC article.
-
Controlled Human Infection Models To Accelerate Vaccine Development.Clin Microbiol Rev. 2022 Sep 21;35(3):e0000821. doi: 10.1128/cmr.00008-21. Epub 2022 Jul 6. Clin Microbiol Rev. 2022. PMID: 35862754 Free PMC article. Review.
-
Resurgence of respiratory syncytial virus with dominance of RSV-B during the 2022-2023 season.Front Microbiol. 2024 Apr 2;15:1376389. doi: 10.3389/fmicb.2024.1376389. eCollection 2024. Front Microbiol. 2024. PMID: 38628867 Free PMC article.
-
Incidence and transmission of respiratory syncytial virus in urban and rural South Africa, 2017-2018.Nat Commun. 2024 Jan 2;15(1):116. doi: 10.1038/s41467-023-44275-y. Nat Commun. 2024. PMID: 38167333 Free PMC article.
References
-
- Moyes J, Cohen C, Pretorius M, et al. Epidemiology of respiratory syncytial virus‐associated acute lower respiratory tract infection hospitalizations among HIV‐infected and HIV‐uninfected South African children, 2010‐2011. J Infect Dis. 2013;208(Suppl 3):S217‐S226. - PubMed
-
- Khor CS, Sam IC, Hooi PS, Chan YF. Displacement of predominant respiratory syncytial virus genotypes in Malaysia between 1989 and 2011. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 2013;14:357‐360. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical